Oramed Patent in Canada Allowed for Oral Delivery of Proteins
NEW YORK, April 7, 2020 /PRNewswire/ — Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Canadian Patent Office has indicated its intent to grant the Company a patent for its invention titled “Methods and Compositions for Oral Administration […]
